News
2021-02-17 09:00
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2021-02-01 13:02
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading Life Science company focused on the digitalisation of medication handling, is announcing the completion of a pilot project with private care provider Attendo. The...
2020-12-22 09:00
In November 2019, iZafe Group AB (publ) (“iZafe” or “the Company”), a leading Life Science company forcused on the digitalisation of medication handling, completed a rights issue in the form of shares and free warrants. The exercise...
2020-12-16 10:45
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading life science company focused on the digitalization of medication management, is announcing that it already at an early stage has received in total 450 pre-orders...
2020-12-16 09:00
Stockholm, Sweden and Espoo, Finland – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading life science company focused on the digitalization of medication management, is announcing the launch of two pilot projects in two Finnish...
2020-12-16 08:30
The exercise period for series TO 8 B warrants issued in connection with the rights issue of units by iZafe Group AB (publ) in November 2019 continues up to and including December 18, 2020. The last day of trading in series TO 8 B warrants on First North...
2020-12-15 11:15
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading company focused on the digitalisation of medication handling, is announcing that it is entering into a collaborative partnership with Doro in Sweden as a direct result...
2020-12-14 17:00
Stockholm, Sweden and Seattle, USA – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading Life Science company focused on the digitalization of medication management announced it has signed a partnership agreement with Hippo Technologies...
2020-12-10 10:00
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B), a leading Life Science company focused on the digitalisation of medication handling, is announcing that it will begin delivering a consumer version of Dosell in spring 2021...
2020-12-08 15:40
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B), a leading life science company in the digitalisation of medication management, has announced that its CEO, deputy CEO and board members intend to utilise their options from...
2020-12-07 16:45
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading Life Science company focused on the digitalisation of medication handling, is launching an updated version of the Dosell medication dispensing robot. Interest...
2020-12-04 08:15
In November 2019 iZafe Group AB (publ) (“iZafe” or “the Company”) carried out a rights issue of units, consisting of shares and series TO 8 B warrants. The subscription period for the series TO 8 B warrants begins on Friday, December...
2020-12-02 15:00
The number of shares and votes in iZafe Group AB has changed due to the issue of 93,571 new Class B shares during November in connection with the exercise of warrants issued in November 2018. Following the exercise of the warrants, the total number of...
2020-11-30 08:32
The subscription price for warrant TO 8 B iZafe Group AB (“iZafe” or “the Company”) has been set at SEK 3.30 in accordance with the applicable option terms. One (1) warrant TO 8 B entitles the holder to subscribe for one (1) B...
2020-11-09 11:45
Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading Life- Science company focused on health care digitalisation, today announces the appointment of Ida Almgren as the new CFO. Ms Almgren will join the company...
2020-11-09 08:52
Stockholm, Sverige – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading Life Science company focused on the digitalisation of medication management, is announcing that it has signed a partnership agreement with Vivago, a Finnish...
2020-11-09 08:33
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today November 9, releases its Q3 Interim Report. Condensed statement of financial performance Significant events during the year Comments by the CEO At the beginning of...
2020-11-04 08:30
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related...
2020-10-15 09:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) (“the company”) reports that a patent application filed by the company has been published. The patent relates to a further development of the medication management robot...
2020-10-02 09:00
Stockholm, Sweden. iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading life science company in the digitalization of medication management – has announced the start of a pilot project with healthcare company TioHundra AB involving...
2018-08-01 12:37
This summer, MediRätt's management team have participated in a series of in-depth interviews to give investors and others a deeper understanding of the company's plans and ambitions ahead. All three interviews are now available with English...